Qizhen Cao
Hubei University of Medicine(CN)The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)Shanghai Institute of Materia Medica(CN)
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research, Nanoplatforms for cancer theranostics, Nanoparticle-Based Drug Delivery, Cell Adhesion Molecules Research
Most-Cited Works
- → Drug delivery with carbon nanotubes for in vivo cancer treatment(2008)2,331 cited
- → Drug Delivery with Carbon Nanotubes for In vivo Cancer Treatment(2008)1,332 cited
- → Peptide-Labeled Near-Infrared Quantum Dots for Imaging Tumor Vasculature in Living Subjects(2006)944 cited
- PET of vascular endothelial growth factor receptor expression.(2006)
- → Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody(2007)240 cited
- → In vitro and In vivo Characterization of 64Cu-Labeled AbegrinTM, a Humanized Monoclonal Antibody against Integrin αvβ3(2006)188 cited
- → Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell